-transparent.png){kind=logo}
The protected nucleoside 1-(2-deoxy-2-fluoro-3,5-di-O-benzoyl-beta-D-arabinofuranosyl)-5-ethylura cil (10) was prepared by condensation of 3,5-dibenzoyl-2-deoxy-2-fluoro-alpha-D-arabinofuranosyl bromide (9) with 2,4-bis-O-(trimethylsilyl)-5-ethyluracil (8). The ratio in this coupling reaction has been raised to 17:1 in favor of the desired beta-anomer. Deprotection by aminolysis gave 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil (FEAU, 1) in 67% isolated yield from the bromo sugar 9. In vitro data show that FEAU has activity against herpes simplex virus types 1 and 2 comparable to that of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-methyluracil (FMAU, 2), 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil (FIAU, 3), and acyclovir (ACV, 12). The cellular toxicity of FEAU was found to be much lower than that of the other nucleoside analogues. Biochemical experiments indicate that FEAU has similar affinity toward thymidine kinases encoded by HSV 1 and 2 and a much lower affinity for cellular thymidine kinase than thymidine. The in vivo antiviral effects of FEAU, FMAU, FIAU, and ACV were evaluated against herpes infection in a systemic mouse encephalitis model and a cutaneous guinea pig model. While FEAU showed activity comparable to that of ACV in the systemic infection model, it was superior in the cutaneous herpes infection model.
M M Mansuri, and
I Ghazzouli, and
M S Chen, and
H G Howell, and
P R Brodfuehrer, and
D A Benigni, and
J C Martin
June 1979,
Journal of medicinal chemistry,
M M Mansuri, and
I Ghazzouli, and
M S Chen, and
H G Howell, and
P R Brodfuehrer, and
D A Benigni, and
J C Martin
October 1999,
Antiviral research,
M M Mansuri, and
I Ghazzouli, and
M S Chen, and
H G Howell, and
P R Brodfuehrer, and
D A Benigni, and
J C Martin
February 1992,
Antiviral research,
M M Mansuri, and
I Ghazzouli, and
M S Chen, and
H G Howell, and
P R Brodfuehrer, and
D A Benigni, and
J C Martin
August 1983,
Cancer research,
M M Mansuri, and
I Ghazzouli, and
M S Chen, and
H G Howell, and
P R Brodfuehrer, and
D A Benigni, and
J C Martin
October 1982,
The Journal of biological chemistry,
M M Mansuri, and
I Ghazzouli, and
M S Chen, and
H G Howell, and
P R Brodfuehrer, and
D A Benigni, and
J C Martin
December 2009,
European journal of nuclear medicine and molecular imaging,
M M Mansuri, and
I Ghazzouli, and
M S Chen, and
H G Howell, and
P R Brodfuehrer, and
D A Benigni, and
J C Martin
January 1990,
Journal of medicinal chemistry,
M M Mansuri, and
I Ghazzouli, and
M S Chen, and
H G Howell, and
P R Brodfuehrer, and
D A Benigni, and
J C Martin
January 1985,
Cancer treatment reports,
M M Mansuri, and
I Ghazzouli, and
M S Chen, and
H G Howell, and
P R Brodfuehrer, and
D A Benigni, and
J C Martin
January 2005,
Proceedings of the National Academy of Sciences of the United States of America,
M M Mansuri, and
I Ghazzouli, and
M S Chen, and
H G Howell, and
P R Brodfuehrer, and
D A Benigni, and
J C Martin
May 2010,
Nuclear medicine and biology,
